Lung Cancer Update cover art

Lung Cancer Update

Lung Cancer Update

By: Dr. Neil Love
Listen for free

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.Copyright 2025 Research To Practice. All Rights Reserved Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
    Jun 18 2026

    Featuring an interview with Prof Martin Reck, including the following topics:

    • Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbinectedin/atezolizumab (0:00)
    • Biology of small cell lung cancer and pharmacodynamics of systemic treatment (3:25)
    • Considerations with maintenance therapy for ES-SCLC (9:31)
    • Considerations with immunotherapy for ES-SCLC (13:12)
    • Curability of SCLC with systemic therapy (15:17)
    • Data with chemoimmunotherapy for patients with poor performance status (25:55)
    • Future developments in therapy for SCLC (30:11)
    • Rapid fire: Small Cell 101 (35:45)

    CME information and select publications

    Show More Show Less
    41 mins
  • Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
    Jun 9 2026

    Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the management of SCLC.

    CME information and select publications

    Show More Show Less
    59 mins
  • EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
    Apr 27 2026

    Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported over the past year.

    CME information and select publications here.

    Show More Show Less
    57 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet